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Integrin signaling to the actin cytoskeleton
Kris A DeMali, Krister Wennerberg and Keith Burridge
Integrin engagement stimulates the activity of numerous
signaling molecules, including the Rho family of GTPases,
tyrosine phosphatases, cAMP-dependent protein kinase and
protein kinase C, and stimulates production of PtdIns(4,5)P2.
Integrins promote actin assembly via the recruitment of
molecules that directly activate the actin polymerization
machinery or physically link it to sites of cell adhesion.
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Abbreviations
Arp2/3 actin-related protein 2/3
cAMP cyclic AMP
CHO Chinese hamster ovary
Crk chicken tumor virus 10 regulator of kinase
DOCK180 180-kDa protein downstream of CRK
ECM extracellular matrix
FAK focal adhesion kinase
GEF guanine nucleotide exchange factor
GAP GTPase-activating protein
GDI guanine nucleotide dissociation inhibitor
ILK integrin-linked kinase
MAP mitogen-activated protein
PAK p21-activated protein kinase
PtdIns(4,5)P2 phosphatidylinositol-4,5-bisphosphate
PINCH particularly interesting new Cys-His protein
PIP 5-kinase phosphatidylinositol 4-phosphate, 5-kinase
PIX PAK-interacting exchange factor
PKA cAMP-dependent protein kinase
PKC protein kinase C
PTP protein tyrosine phosphatase
SCAR suppressor of cAMP receptor
SHP-2 Src homology region 2 containing PTP-2
SHPS-1 SHP substrate-1
SFK Src family kinase
WAVE WASP family verprolin-homologous protein
WASP Wiskott–Aldrich syndrome protein
Introduction
Twelve years ago, the discovery that integrin engagement
stimulates tyrosine phosphorylation of several proteins
ushered in an era of extensive research on the signaling
that occurs downstream from integrins. Many signaling
pathways that emanate from integrin engagement or
clustering have been identified and the pace of discovery
in this field has not slowed down. This is not surprising
given that adhesion to the extracellular matrix (ECM)
influences the growth, differentiation, survival, morphol-
ogy and migratory properties of cells. We suspect that
more pathways remain to be uncovered. In this brief
review we will restrict our focus to a few selected topics,
particularly concentrating on the signaling pathways
downstream from integrin engagement that impact on
the organization of the cytoskeleton and on cell migration.
Three dimensions versus two
Although there is a long history of studying the behavior
of cells in collagen gels, most work on integrins has
involved cells grown on 2D surfaces coated with ECM
components derived from serum; these components may
be synthesized by the cells themselves or applied by the
experimenter. In such cultures, integrins are prominently
concentrated in matrix adhesions, which include focal
complexes, focal adhesions and fibrillar adhesions. These
structures have been discussed elsewhere [1]. Briefly,
focal complexes are small transient adhesions at the cell
periphery, regulated by Rac or Cdc42. Under the influ-
ence of RhoA activity and tension, focal complexes grow
in size to become focal adhesions — larger, more stable
structures. Fibrillar adhesions — adhesions made to
fibronectin fibrils — contain the a5b1 integrin and a
subset of the proteins found in focal adhesions [2]. Of
these structures, focal adhesions are often the most pro-
nounced in 2D cultures but are rarely seen in vivo and are
much less apparent in cells growing in 3D ECMs [3].
Focal adhesions continue to provide a valuable model for
studying the organization of and signaling from relatively
stable integrin aggregates, but attention has recently been
directed to studying integrin organization and signaling in
3D situations. Unlike cells on 2D surfaces, which have a
spread morphology, fibroblasts in 3D matrices develop
elongated or stellate morphologies and migrate more
rapidly. These cells develop 3D-matrix adhesions that
resemble fibrillar adhesions, both in their dimensions and
in that the integrin a5b1 is present, but unlike fibrillar
adhesions these matrix adhesions are rich in paxillin, focal
adhesion kinase (FAK) and phosphotyrosine [3]. Surpris-
ingly, phosphorylation of the major FAK phosphorylation
site (Y397) was not detected, suggesting that the signaling
pathways downstream from integrins may differ in 2D
and 3D cultures [3].
The physical state of the matrix affects the structure of
the adhesions and the morphology of cells, and it is
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possible that this is a major factor contributing to the
differences between 2D and 3D cultures. On rigid 2D
surfaces focal adhesions are favored [4,5], whereas fibrillar
adhesions develop when a pliable fibronectin matrix is
remodeled to form fibrils [5]. In 3D collagen gels, fibro-
blasts at low density display a stellate or dendritic mor-
phology and adhesions to the matrix appear to be
diffusely distributed over the cell surface [6]. At high
cell density fibroblasts contract the collagen gels, thereby
increasing their rigidity. Under these conditions, struc-
tures similar or equivalent to focal adhesions develop in a
RhoA-dependent manner [6]. These results raise the
possibility that the development of a rigid matrix result-
ing from the initial contractile activity of the cells leads to
subsequent isometric tension that may somehow elevate
RhoA activity.
Integrin-mediated regulation of Rho family
GTPases
With respect to cytoskeletal organization and cell migra-
tion, signaling from integrin-mediated adhesion is typi-
cally characterized by two phases. Early adhesion is
associated with pathways that stimulate protrusion
whereas mature adhesions are associated with the devel-
opment of tension. The early phase leads to Rac and
Cdc42 activation and to actin polymerization. The later
phase leads to RhoA activation, increased contractility
and the transmission of tension to the sites of integrin
ligation. These pathways are often antagonistic and the
biphasic nature and timing of this response can be a
source of complexity and confusion.
Regulation of Rac and Cdc42
During adhesion and spreading on an ECM, cells extend
filopodia and lamellipodia, structures regulated by Cdc42
and Rac, respectively. Integrin-mediated adhesion acti-
vates Cdc42 and Rac [7] and for Rac this requires an intact
b integrin subunit [8,9]. Rho family GTPases are active
when GTP-bound and inactive when bound to GDP.
Activation is catalyzed by guanine nucleotide exchange
factors (GEFs) and inactivation is promoted by GTPase-
activating proteins (GAPs) that stimulate the intrinsic
GTPase activity of the Rho proteins. One example of a
GEF activated downstream from integrin engagement is
Vav1 [10], but its expression is restricted to hematopoietic
cell types. However, the closely related GEF Vav2 is
widely distributed and an obvious candidate for activation
downstream from integrins (Figure 1). Using tyrosine
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Integrin-mediated activation of Rac and Cdc42. In response to integrin engagement, several tyrosine kinases are activated, including FAK and Src.
These tyrosine kinases phosphorylate substrates, leading to the activation of Rac and Cdc42 (only Rac is indicated). The phosphorylated proteins
include the following: GEFs (yellow circles), which activate Rac and Cdc42, such as Vav; adaptor protein complexes (blue circles) such as paxillin and
PKL or p130Cas, Crk, and ELMO that bind GEFs such as PIX or DOCK180. Alternatively, integrins trigger translocation of RhoGDI-bound Rac–GTP to
the plasma membrane where active Rac is liberated and available to interact with effectors.
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phosphorylation as an indicator of activation, evidence
was presented that Vav2 is activated downstream from
growth factor receptors but not from integrins [11,12].
Nevertheless, a dominant-negative form of Vav2 blocked
lamellipodium formation and spreading on fibronectin,
which is consistent with Vav2 having a role in Rac
activation following integrin engagement [13]. Interest-
ingly, an elevation in tyrosine phosphorylation was not
seen in response to adhesion, which is consistent with the
earlier work and suggests that changes to multiple phos-
phorylation sites might have masked an elevation in
phosphorylation of the site(s) associated with activation,
or that Vav2 activation occurs by other means.
Other pathways downstream of integrins that lead to Rac
activation may also be involved. Both p130cas and pax-
illin associate with FAK and both have been linked to Rac
activation. Tyrosine phosphorylation of p130cas promotes
a complex of Crk, ELMO and DOCK180 [14–18,19]
(Figure 1). Recent work has revealed that DOCK180 is a
Rac GEF, even though it lacks the Dbl-homology/pleck-
strin-homology tandem domains characteristic of conven-
tional Rho-family GEFs [19,20]. Another complex
also associates with paxillin: this complex includes
PKL (GIT) and Pak-interacting exchange factor (PIX),
the latter being a conventional Rac GEF (reviewed in
[21]) (Figure 1). Deciphering the relative importance of
the different pathways that potentially lead to Rac activa-
tion following integrin engagement will be important.
Integrin-mediated activation of Rac and other Rho-family
proteins may involve not only GEF activation but also
targeting of the GTP-bound protein to sites of adhesion.
Del Pozo and coworkers have found that a fraction of
active Rac is sequestered by RhoGDI and that this active
Rac is selectively released close to sites of integrin-
mediated adhesion, allowing it to interact with effectors
in this region of the cell [22]. It will be interesting to
determine how this is achieved and whether localized
release of active Rho family members from RhoGDI is a
general mechanism.
Regulation of RhoA
Integrin engagement leads to a transient depression in
RhoA activity [23] and it has been argued that this
promotes lamellipodial extension during cell migration
[24]. The dip in RhoA activity requires Src, FAK and
p190RhoGAP [25,26]. A role for paxillin phosphorylation
has also been indicated in this decrease in RhoA activity.
When two of the paxillin phosphorylation sites (Y31 and
Y118) were mutated, the depression in RhoA activity was
abolished and the cells showed premature formation of
stress fibers [27]. These authors demonstrated that the
phosphorylation of these two tyrosines, which is induced
by integrin-mediated adhesion, generates a binding site
for p120RasGAP, displacing it from its binding partner
p190RhoGAP. Evidence was presented that p190Rho-
GAP freed from p120RasGAP was activated and hence
contributed to the decrease in RhoA activity [27]. How-
ever, whether the interaction of p120RasGAP with
p190RhoGAP inhibits or increases the latter’s activity
remains controversial. Interestingly, the decrease in
RhoA activity is seen even with cells in suspension that
bind soluble-peptide integrin ligands [25], a situation in
which FAK does not become activated and paxillin does
not become phosphorylated on these tyrosine residues.
This suggests that the phosphorylation of paxillin cannot
be the sole mechanism of regulation and that phosphor-
ylation of p190RhoGAP may also be important [25].
Nevertheless, paxillin phosphorylation may contribute
to the depression of RhoA activity when cells adhere
to fibronectin, which results in a more robust inhibition of
the RhoA response than is seen in cells in suspension
stimulated with soluble ligands.
Examination of the time-course of RhoA activity in
response to cells adhering to fibronectin reveals that
the initial dip is followed by activation [23]. Engagement
of non-integrin receptors such as syndecan-4 may con-
tribute to this response [28–30], but integrins have also
been observed to contribute to activation. Here, different
responses have been observed with different integrins.
O’Connor and colleagues observed that engagement or
clustering of a6b4 resulted in stimulation of RhoA activ-
ity, in contrast to the depression induced by clustering b1
integrins [31]. Engagement of avb3 on astrocytes by
Thy-1 was shown to stimulate assembly of focal adhe-
sions and stress fibers, which is consistent with RhoA
activation occurring downstream from this integrin [32].
Direct evaluation of the effect of b1 and b3 integrins on
RhoA activity was performed in Chinese hamster ovary
(CHO) cells in which these integrins were overexpressed
[33]. In this system, overexpression of b3 resulted in a
pronounced increase in Rho–GTP levels when the cells
were plated on fibronectin or fibrinogen, whereas b1
overexpression had no effect. Somewhat surprisingly,
expression of a b1/b3 chimera in which a heptapeptide
sequence from the b1 extracellular-I-domain-like struc-
ture was replaced by the equivalent sequence from theb3
integrin resulted in stimulation of Rho activity [33]. A
different result was found using cells deficient in b1
integrins [34]. Using either GD25 or GE11 cells, re-
expression of b1 subunits stimulated RhoA activity,
whereas b3 had no effect. Although the results were
the opposite in the two studies, both studies found that
the extracellular domain was critical. A possible explana-
tion for the opposite results is the different cell types
used by these two groups. It is easy to imagine that the
requirements of a particular integrin may differ in dif-
ferent cell types, and that in some situations, but not
others, it is advantageous for the integrin to be coupled to
Rho activation. The large number of RhoGEFs and their
variable expression in different cell types may provide
cell-type specificity when coupling integrins to Rho
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activation. The significance of the extracellular domains
of the integrins in this coupling remains unclear.
Integrins and protein tyrosine phosphatases
Integrin-mediated adhesion induces the tyrosine phos-
phorylation of many proteins. The consequences of this
tyrosine phosphorylation and the kinases involved have
commanded much attention. By comparison, the protein
tyrosine phosphatases (PTPs) have been much less
studied, although several recent papers suggest that this
is changing. Early work indicated that integrin-mediated
adhesion results in a bulk inhibition of PTP activity that
parallels the increase in tyrosine phosphorylation seen in
response to adhesion [35]. Sastry and coworkers, however,
have found that PTP–PEST is stimulated upon integrin-
mediated adhesion [36]. This PTP had previously been
shown to act on various focal adhesion targets such as
p130cas [37] and paxillin [38], but not on FAK. Both
overexpression and deletion of PTP–PEST inhibit cell
migration [39,40], suggesting that a fine balance in the
level of tyrosine phosphorylation of relevant substrates
regulates cell migration. PTP–PEST overexpression
inhibits protrusive activity and this has been related to
a depression in Rac activity [36]. As mentioned above,
the tyrosine phosphorylation of both p130cas and paxillin
has been linked to Rac activation, and so PTP–PEST
may be affecting Rac activity by dephosphorylating these
known targets.
One PTP that has been associated both with integrin-
mediated signaling and with regulating RhoA activity is
SHP-2 (Src homology region 2 containing PTP-2). Per-
turbation of SHP-2 levels or activity has effects on adhe-
sion, cytoskeletal organization and cell migration [41–45].
Conflicting results have been obtained with respect to
SHP-2’s effect on Rho activity, with some groups detect-
ing activation [45,46] and others inhibition [47,48]. It is
difficult to reconcile these differences; however, it is
possible that in different cellular contexts SHP-2 acts
on different targets that influence RhoA activity in oppo-
site directions (Figure 2). Recent work has identified
p190BRhoGAP as a potential target for SHP-2 [49].
Here tyrosine phosphorylation has been associated with
increased GAP activity and so the action of SHP-2 to
decrease p190 activity will result in elevated RhoA activity
[49]. By contrast, the activity of some GEFs (e.g. the Vav
family, PDZ–RhoGEF and leukemia-associated Rho-
GEF) is stimulated by tyrosine phosphorylation [50–52].
Although Vav2 has broad specificity for Rho family
GTPases in vitro, in vivo the phenotype resulting from
activated Vav2 varies with cell type, often suggesting
increased Rac activity but at other times increased RhoA
activity as well [12]. SHP-2 will exert an inhibitory effect on
RhoGEFs that are stimulated by tyrosine phosphorylation.
One of the substrates for SHP-2 is the transmembrane
protein SHP substrate 1 (SHPS-1, also known as SIRPa1),
which becomes tyrosine-phosphorylated in response to
integrin-mediated adhesion by FAK and Src family
kinases [53]. SHPS-1 binds SHP-2, thereby targeting
SHP-2 to the membrane, where it may act on other
tyrosine-phosphorylated proteins. Expression of a trun-
cated form of SHPS-1 lacking most of the cytoplasmic
domain and unable to bind SHP-2 results in cells with
increased stress fibers [45]. Contrary to expectations
these cells exhibit reduced rather than elevated RhoA
activity [45]. The reason for this paradoxical result has
not been resolved.
Figure 2
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Model for the potential regulation of Rho activity by tyrosine phosphatases. Left: a tyrosine phosphorylated activated GEF (green ovals) is
dephosphorylated by a tyrosine phosphatase (shown in pink). The GEF is unable to catalyze the exchange of GTP for GDP and Rho is left in the
inactive GDP-bound form (purple circles). Right: the phosphatase dephosphorylates a GAP (orange ovals), inactivating it, and Rho–GTP levels
accumulate (purple starbursts).
Integrin signaling to the actin cytoskeleton DeMali, Wennerberg and Burridge 575
www.current-opinion.com Current Opinion in Cell Biology 2003, 15:572–582
In some situations, engagement of integrins with their
ligands promotes integrin association with lipid rafts
(reviewed in [54]). SHP-2 is targeted to rafts in response
to integrin binding to its ligands [55]. Significantly, the
use of a double palmitoylation signal to target SHP-2 to
lipid rafts in cells in suspension stimulates FAK tyrosine
phosphorylation and other pathways normally triggered
by integrin engagement [55]. Targeting SHP-2 to lipid
rafts also affected Rho activity: the resting level of active
Rho was elevated, but a dip in activity was still observed
in response to adhesion to fibronectin. Interestingly,
when a catalytically dead form of SHP-2 was targeted
to lipid rafts, the level of Rho activity returned to more
normal levels, but the adhesion-induced dip was abol-
ished. These results led the authors to conclude that
SHP-2 can function as both a positive and negative
regulator of RhoA activity [55]. The elevation of Rho
activity by SHP-2 in lipid rafts could be explained by the
regulation of p190RhoGAP phosphorylation and activity
[49]. However, the fact that catalytically inactive SHP-2
blocks the adhesion-induced dip in Rho activity suggests
that p190RhoGAP is not becoming activated in this
situation. It would be possible to explain this observation
if, in response to integrin engagement, SHP-2 promotes
Src activation by removing Src’s inhibitory C-terminal
phosphate [43]. The catalytically inactive SHP-2 would
block this pathway and thereby prevent the tyrosine phos-
phorylation of p190RhoGAP and consequent depression of
Rho activity. The different observations obtained with
SHP-2 illustrate the complexity of these pathways and
how PTPs may act at multiple sites in a pathway, often
generating paradoxical results (illustrated in Figure 2).
PTPa, another PTP implicated in promoting cell spread-
ing [56] and found in focal adhesions [57], removes
inhibitory phosphates from the C-terminal tyrosines of
Src family kinases (SFKs) [56,58]. Cells lacking PTPa
reveal decreased FAK phosphorylation, particularly on
tyrosine 397, the autophosphorylation site, leading to the
suggestion that PTPa activity lies between integrin
engagement and FAK activation in the pathway [59].
Strong support for this idea comes from another study in
which PTPa has been found to physically associate with
the integrin avb3 but not with a5b1 [60]. This work built
on earlier studies showing that avb3 integrin signaling via a
Src family kinase is involved in the reinforcement of
integrin–cytoskeleton linkages [61]. The decrease in focal
adhesions seen in the PTPa null cells, together with their
decreased development of force transmitted to avb3 integ-
rins [60], suggests that PTPamay normally contribute to
the activation of RhoA downstream from avb3 integrin
engagement. In preliminary work, our laboratory has
confirmed that PTPa null cells exhibit decreased
RhoA–GTP levels when plated on fibronectin (Eller-
broek and Burridge, unpublished observations). As men-
tioned earlier, in some cells b3 integrin engagement
activates RhoA [33] and it seems likely this occurs via
a PTPa/SFK pathway. At first, this seems to conflict with
the idea that SFKs downstream from integrin engage-
ment depress RhoA activity via p190RhoGAP [25]; how-
ever, an explanation is suggested by the finding of von
Wichert and coworkers that it is Fyn rather than Src that
becomes activated by PTPa downstream of avb3 integrin
occupancy [60]. These investigators found that over-
expression of Src in cells expressing PTPa actually
depressed focal-adhesion formation, whereas this was
not seen with Fyn [60]. Together these results suggest
a model in which the initial depression of RhoA activity
occurs via integrin-mediated activation of Src leading to
elevated p190RhoGAP activity, whereas the slower
increase in RhoA activity occurs as a result of PTPa’s
activation of Fyn (Figure 3). Presumably this involves a
RhoGEF that is stimulated by tyrosine phosphorylation.
It will be interesting to determine whether other integrins
may also couple to PTPa in some situations or cell types,
and whether this may account for the elevation of RhoA
Figure 3
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Role of Src family kinases in the inhibition and reactivation of Rho
activity. During the first 10–30 minutes of adhesion via some integrins,
the activity of Rho is transiently suppressed. The pathway to inhibition
involves c-Src-dependent phosphorylation and activation of
p190RhoGAP. This GAP triggers the hydrolysis of GTP bound to Rho
rendering it inactive. With other integrins, or with the same integrins at
later times (45–90 minutes) of adhesion, the levels of Rho–GTP increase
as a result of PTPa activating the tyrosine kinase, Fyn, which
presumably phosphorylates and activates a RhoGEF.
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activity downstream from a5b1 integrins observed by
Danen and coworkers [34].
Integrin regulation of cAMP/PKA
The activity of cAMP-dependent protein kinase (PKA)
regulates the cytoskeleton both by inhibiting contractility
and by stimulating protrusion. PKA can inhibit actin–
myosin contractility in several ways. It can phosphorylate
the Ga13 subunit of heterotrimeric G proteins, leading to
decreased downstream RhoGEF activation [62]; it can
directly phosphorylate the C terminus of RhoA, resulting
in an increased binding to RhoGDI and thereby terminate
RhoA activity [63,64]; and finally, it can phosphorylate and
inactivate myosin light chain kinase [65]. All these beha-
viors lead to decreased actin–myosin contractility. In addi-
tion, PKA has been shown to phosphorylate and inhibit
vasodilator-stimulated phosphoprotein (VASP) [66] and
p21-activated protein kinase (PAK) [67], and to activate
Rac1 and Cdc42 [68,69]. Increased levels of cAMP or
activation of PKA in cells inhibit RhoA activation [70]
and lead to loss of stress fibers and focal adhesions [63].
Conversely, inhibition of PKA results in formation of stress
fibers [71,72] and allows adhesion-independent mitogen-
activated protein (MAP) kinase activation [66].
While PKA regulates adhesion, integrin ligation and cell
adhesion in turn are potent regulators of PKA activity.
Detachment of cells causes a transient activation of PKA
[66], probably through a relaxation-dependent mechan-
ism [73]. The detachment-dependent activation of PKA
prevents anchorage-independent activation of MAP
kinase by inactivating PAK [67]. PKA activity in sus-
pended cells, however, returns to baseline levels within
60–90 minutes. Somewhat surprisingly, adhesion will also
activate PKA [66,68]. The time-course of this correlates
with the activation of Rac and Cdc42 [7,74], the inactiva-
tion of RhoA [23], and the timing of membrane protru-
sions during cell spreading. Similarly, ligand-dependent
clustering of b1 integrins by function-blocking b1 anti-
bodies or soluble-peptide integrin ligands induces activa-
tion of PKA [75,76]. As with the detachment-dependent
activation of PKA, the attachment-dependent activation
of PKA is transient [66,68] and the later reduction in PKA
activity allows cells to form stress fibers and focal adhe-
sions, adhere firmly, and sustain survival signals, possibly
through MAP kinase signaling [67,71,72]. The deactiva-
tion, at least in endothelial cells, is matrix- and integrin-
dependent: integrins a1b1, a2b1, or a5b1 can support
inactivation but a6b1 or aVb3 cannot [71,72].
An interplay between integrins and protein
kinase C
Protein kinase C (PKC) a was one of the first signaling
molecules identified in focal adhesions [77] and subse-
quent work has established that isoforms of PKC become
activated following adhesion to the ECM and cell spread-
ing [78–80,81]. For example, in muscle cells activation of
PKCe is followed sequentially by activation of PKCa and
PKCd [81]. Whereas activation of PKC promotes cell
spreading and focal adhesion formation in fibroblasts
[28], it should be noted that PKC stimulation (e.g. by
phorbol esters) induces disruption of focal adhesions in
epithelial cells [82,83]. In fibroblasts, early work estab-
lished that adhesion to the cell-binding domain of fibro-
nectin mediated by a5b1 is insufficient for cells to
develop focal adhesions, but assembly of these structures
could be stimulated by PKC activation or by the addition
of the heparin-binding domain of fibronectin (reviewed
in [84]). The relevant proteoglycan responsible for
promoting focal adhesion assembly was identified as
syndecan-4, a transmembrane proteoglycan that binds
to the heparin-binding domain of fibronectin (reviewed
in [84]). Syndecan-4 localizes to focal adhesions and
PKCa binds to syndecan-4’s cytoplasmic domain
(reviewed in [84]). Recent work has revealed an inter-
esting level of complexity. Whereas the integrin a5b1
requires PKCa activation via syndecan-4 for focal adhe-
sions to develop, the integrin a4b1, which binds to
another site in fibronectin, does not [85]. Other inter-
esting differences exist between these two integrins,
such as the binding of paxillin by the a4 cytoplasmic
domain [86], which prompts the question of whether the
recruitment of paxillin or some other protein by a4b1
fulfills functions that may be supplied by PKCa activa-
tion downstream from a5b1 engagement. Downstream
from syndecan-4 engagement, multiple studies have
implicated RhoA activation as well as PKC activation
[29,87], raising the possibility that PKC may be upstream
of RhoA. This has recently been validated with the
demonstration that the RhoA-GEF p115 is a substrate
for and stimulated by PKCa [88].
Regulation of PtdIns(4,5)P2 by integrin
signaling
The activities of many cytoskeletal proteins are regulated
by phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2).
Downstream from integrins, both vinculin and talin
undergo a conformational change on binding this mole-
cule. With vinculin, this exposes cryptic binding sites for
other proteins, including talin [89–91], whereas talin’s
interaction with PtdIns(4,5)P2 promotes its binding to
the cytoplasmic domain of b1 integrin subunit [92].
Significantly, integrin-mediated adhesion stimulates
PtdIns(4,5)P2 synthesis [93]. In part, this may occur via
stimulation of PI5-kinase by Rho and Rac, although the
mechanism by which this could occur is not well under-
stood. Recent work has revealed another pathway. Inde-
pendently, two groups have found that one PIP 5-kinase
splice isoform localizes to focal adhesions by binding to
talin and that this interaction stimulates its activity
[94,95]. In one case, the direct interaction was found
to stimulate PIP 5-kinase activity, whereas in the other
case localization to focal adhesions resulted in activation
by FAK phosphorylation. This phosphorylation of PIP
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5-kinase not only stimulated catalytic activity but also
increased its association with talin [94]. The binding of
PIP 5-kinase to talin and its consequent activation should
elevate PtdIns(4,5)P2 levels in the local region where
integrins are clustered. The positive feedback mechan-
ism suggested by these findings should contribute to the
assembly of these integrin-based complexes. Indeed,
expression of a kinase-dead form of the relevant PIP
5-kinase isoform blocked recruitment of FAK to focal
adhesions. The local increase in PtdIns(4,5)P2 in the
vicinity of integrin engagement may also stimulate actin
polymerization, as discussed below.
Regulation of actin assembly by integrins
Several of the prominent integrin-associated structural
proteins (talin, vinculin and a-actinin) bind F-actin, but
relatively little polymerization of actin has been detected
in focal adhesions. As mentioned above, localized
PtdIns(4,5)P2 synthesis in focal adhesions may contribute
to the assembly of protein complexes and the binding of
actin at these sites. It may also promote the limited
polymerization that occurs in focal adhesions by dissociat-
ing capping proteins from the barbed ends of actin fila-
ments [96] or by other mechanisms. Much more
polymerization of actin occurs at the leading edge of
cells, which is also the region where integrins first engage
their ligands. The major nucleator of actin polymerization
is the actin-related protein 2/3 (Arp2/3) complex. Recent
work has established a link between the Arp2/3 complex
and new sites of integrin engagement that is mediated by
the Arp2/3 complex binding to vinculin [97] (Figure 4a).
This interaction is transient, being confined to the newest
adhesions and not seen in more mature focal adhesions.
The association is regulated by phosphatidylinositol-3-
kinase and Rac activity. Cells deficient in vinculin show
decreased spreading and formation of lamellipodia, phe-
notypes corrected by re-expression of wildtype vinculin
but not of vinculin unable to bind the Arp2/3 complex
[97]. Although this interaction does not stimulate actin
polymerization by the Arp2/3 complex, it does recruit the
Arp2/3 complex to sites of integrin clustering.
Other mechanisms for linking actin polymerization to
integrins have also been identified. Key regulators of
the Arp2/3 complex are members of the Wiskott–Aldrich
syndrome protein (WASP) family of proteins, including
WASP, N-WASP and WAVE/SCAR proteins. N-WASP
has been identified in b1-integrin immunoprecipitates
and was released under conditions stimulating actin poly-
merization and protrusion [98]. The WASP proteins sti-
mulate the Arp2/3 complex after they have undergone a
conformational change in which the C-terminal domain is
exposed, enabling it to bind the Arp2/3 complex. WASP
and N-WASP are activated by binding to Cdc42 or Nck,
whereas WAVE/SCAR is activated downstream from Rac
or Nck [99,100,101]. Nck also binds to WIP, a WASP-
interacting protein that promotes actin polymerization
[102]. A link between Nck and integrins has been iden-
tified via the LIM domain protein, PINCH, which binds
integrin-linked kinase (ILK), which in turn associates
with integrin b subunit cytoplasmic domains [103]
(Figure 4b). Significantly, the action of WASP on Arp2/
3-induced actin polymerization is stimulated by
PtdIns(4,5)P2, which, as mentioned above, is synthesized
by enzymes recruited to sites of integrin engagement by
binding talin [94,95].
Figure 4
PINCH
ILK
(b)(a)
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Links between the actin polymerization machinery and integrins. (a) Activated Arp2/3 complex binds directly to the hinge region of vinculin, an
adhesion molecule that is recruited to integrins via an interaction with talin. Binding of the Arp2/3 complex to vinculin does not stimulate the activity of
the Arp2/3 complex, but rather localizes polymerization to new sites of integrin adhesion. (b) Actin polymerization is stimulated at sites of integrin
clustering via recruitment of a complex of proteins, including ILK–PINCH and Nck. Nck binds and activates WASP proteins, which in turn recruit and
activate the Arp2/3 complex.
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The above observations suggest that the machinery for
nucleating actin polymerization can be linked in various
ways to integrins and may be particularly active where
integrins are newly engaged with the ECM. Superim-
posed on these physical links between integrins and the
Arp2/3 complex is the activation of Rac and Cdc42 down-
stream from integrin ligation. The local activation of
these GTPases will further stimulate WASP or WAVE/
SCAR in the vicinity of integrin–ligand binding. Addi-
tionally, selective release of activated Rac from the
sequestering protein RhoGDI has been reported to occur
where integrins mediate adhesion to the ECM [22].
Together, these pathways should synergize to promote
actin polymerization at sites of new adhesion.
Conclusions
Progress in the field of integrin-mediated signaling has
been substantial in the last couple of years, but much still
remains to be learned. The apparent complexity of many
of the signaling pathways downstream from integrin
ligation reflects in part the transition from an early
response, associated with Rac/Cdc42 activation and mem-
brane protrusion, to a late response, associated with RhoA
activation and the generation of tension. The develop-
ment of live cell imaging techniques should contribute to
resolving many of the spatial and temporal complexities
downstream from integrin engagement. Biosensors are
being designed and tested that will visualize specific
signaling events, such as activation of Rho GTPases,
kinases and phosphatases, within living cells in real time.
This technology promises to revolutionize the field by
allowing signaling pathways to be visualized locally
within cells as integrin ligation occurs, matures and is
terminated.
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